Translational MRI studies of mild traumatic brain injury (mTBI)
Translational MRI studies of mild traumatic brain injury (mTBI)

Translational MRI studies of mild traumatic brain injury (mTBI)

On Demand Session

Webinar Overview

Imaging and blood biomarker studies done in young males and females in our Centre have raised serious questions about return to play guidelines and rule changes for juvenile ice hockey and university rugby. Our results indicate potentially long term structural and functional changes in brains during these critical developmental years, even in individuals not reporting a concussion. To further explore these changes in a more controlled manner, we have developed a human relevant preclinical mouse model of mTBI that is much milder than what has been previously reported and which better mimics the rotational biomechanics of most mTBI. We use humanized mouse models with risk factors for Alzheimer’s Disease in addition to control animals to evaluate the time course of changes in resting-state fMRI and micro FA DTI along with careful touchscreen cognition tasks and immunofluorescence microscopy. By carefully characterizing the changes at the mesoscopic and microscopic scales using MRI and other biological probes, we can learn a great deal about the interplay between mTBI and future dementia risk.

This study is funded by the US Department of Defence, Brain Canada and BrainsCAN (The Canada First Research Excellence Fund).

Speaker

Ravi Menon

Western University

Dr. Ravi Menon, FCAHS, FRSC, is Professor of Medical Biophysics and Medical Imaging at Western University, where he is also a member of the Graduate Program in Neuroscience and the Graduate Program in Biomedical Engineering. He is founder and Scientific Director of Western’s Centre for Functional and Metabolic Mapping (CFMM), Canada’s National ultra-high field MRI facility. He is also Co-Scientific Director of Western’s $66M CFREF Award, BrainsCAN.

He is a Fellow of the Royal Society of Canada, Canada’s highest academic honour in the arts and sciences. He is also a Senior Fellow of the International Society for Magnetic Resonance in Medicine and the Canadian Academy of Health Sciences. He was twice an awardee of Canada’s Top 40 under 40 program and a recipient of the Explorers Medal from the Canadian Institute for Advanced Research and is a Tier 1 Canada Research Chair Emeritus.

He has served in numerous advisory capacities, including 7 years on the Canada Gairdner Foundation, TRIUMF’s advisory board and on the Board of Scientific Councilors of NIMH/NIH. He served for 7 years (the last 4 as Chair) on the Institute Advisory Board of the Institute for Neuroscience, Mental Health and Addiction of the CIHR. He currently sits on the Board of the Brain Canada Foundation, Canada’s largest charitable funder of brain research.

Registration

Input value is invalid.

Are you already in contact with your Bruker representative regarding any product inquiries?

We constantly want to improve our service for our customers. In answering the following question you help us to serve your needs even better in the future: What best describes your situation?

By ticking this box, I agree to receive, from time to time, emails from Bruker and its affiliates within the Bruker Group on upcoming events, webinars, our products and services, surveys and Bruker's corporate news.
I can unsubscribe at any time, by contacting Bruker or clicking on the opt-out link in the email if available. For more information on the processing of your personal data, please check Bruker’s Privacy Policy. 

By submitting this form I agree my personal data will be used to process my registration to the webinar. I have read and accepted the Bruker Website Privacy Notice (https://www.bruker.com/privacy-policy.html) and I agree to the Terms of Use (https://www.bruker.com/terms-of-use.html) of the Bruker website.

Already registered and lost your invitation link?

Thank you. The invitation link has been resent.